All sites C00-96,D32-33,D42-43,D45-47,D76 665 92.1 2.3 2.2 2.1 1.3
Mouth, pharynx C00-14 13 98.4 1.6 - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 85.7 14.3 - - -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 135 89.2 1.3 2.7 4.1 2.7
  Oesophagus C15 8 97.5 - - 2.5 -
  Stomach C16 15 96.1 - - 2.6 1.3
  Small intestine C17 2 100.0 - - - -
  Colon C18 39 98.5 - - 1.0 0.5
  Rectum, rectosigmoid C19-20 30 98.7 - - 0.7 0.7
  Anus C21 0 100.0 - - - -
  Liver C22 13 80.6 6.0 3.0 6.0 4.5
  Gallbladder, bile ducts C23-24 3 85.7 - - 7.1 7.1
  Pancreas C25 23 59.0 4.3 13.7 14.5 8.5
  Other digestive organs C26 1 85.7 - - - 14.3
Respiratory organs C30-39 71 71.1 10.7 9.6 7.0 1.7
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 6 100.0 - - - -
  Lung, trachea C33-34 65 68.4 11.8 10.2 7.7 1.9
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 80.0 20.0 - - -
Melanoma of the skin C43 27 100.0 - - - -
Skin, non-melanoma C44 41 100.0 - - - -
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 4 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 223 99.4 - 0.2 0.4 -
  Prostate C61 216 99.4 - 0.2 0.5 -
  Testis C62 5 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 58 93.5 1.4 1.7 1.0 2.4
  Kidney C64 25 86.3 1.6 4.0 2.4 5.6
  Bladder and urinary tract2 C65-68 34 98.8 1.2 - - -
Eye C69 1 60.0 - 20.0 20.0 -
Brain, central nervous system C70-72,D32-33,D42-43 15 100.0 - - - -
Thyroid gland C73 3 100.0 - - - -
Other endocrine glands C74-75 1 71.4 - 28.6 - -
Illdefined or unknown C76,C80 10 71.2 9.6 7.7 5.8 5.8
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 57 85.7 6.6 2.1 2.1 3.5
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 23 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 10 69.4 6.1 10.2 6.1 8.2
  Leukaemia C91-95 14 72.9 20.0 1.4 1.4 4.3
  Myelodysplastic syndromes D46 2 37.5 12.5 - 12.5 37.5
  Myeloproliferaitive neoplasms D45,D47 6 93.8 3.1 - 3.1 -
Not included above
  Basal cell carcinoma of the skin 159 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.